128 related articles for article (PubMed ID: 37587896)
1. Exercise attenuates neuronal degeneration in Parkinson's disease rat model by regulating the level of adenosine 2A receptor.
Li R; Jin S; He J; Peng Y; Wei L; Gu L
Folia Neuropathol; 2023; 61(2):217-223. PubMed ID: 37587896
[TBL] [Abstract][Full Text] [Related]
2. Exercise attenuates mitochondrial autophagy and neuronal degeneration in MPTP induced Parkinson's disease by regulating inflammatory pathway.
Li Z; Lv H; Cui X; Di W; Cheng X; Liu J; Tripathi A
Folia Neuropathol; 2023; 61(4):426-432. PubMed ID: 38174683
[TBL] [Abstract][Full Text] [Related]
3. Exercise improves the body function and protects the neuronal injury in Parkinson's disease rats by activating calpain 1 and kallikrein 6.
Guo J; Yang J; Fu J; Tripathi A
Folia Neuropathol; 2022; 60(3):301-307. PubMed ID: 36382482
[TBL] [Abstract][Full Text] [Related]
4. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
5. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
[TBL] [Abstract][Full Text] [Related]
6. An overview of adenosine A2A receptor antagonists in Parkinson's disease.
Jenner P
Int Rev Neurobiol; 2014; 119():71-86. PubMed ID: 25175961
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin improved the cognitive function through regulating adenosine A
Huang SY; Su ZY; Han YY; Liu L; Shang YJ; Mai ZF; Zeng ZW; Li CH
Phytomedicine; 2023 Feb; 110():154649. PubMed ID: 36634379
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of 5-HT1b/1d agonist on Parkinson's disease by modulating glutamate and reducing deposition of α-synuclein.
Tripathi AS; Fatima N; Tripathi P; Tripathi R; Alka ; Zaki MEA; Mohapatra L; Yasir M; Maurya RK
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23627. PubMed ID: 38229316
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum.
Strömberg I; Popoli P; Müller CE; Ferré S; Fuxe K
Eur J Neurosci; 2000 Nov; 12(11):4033-7. PubMed ID: 11069599
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
[TBL] [Abstract][Full Text] [Related]
13. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
14. Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson's disease.
Uchida S; Kadowaki-Horita T; Kanda T
Int Rev Neurobiol; 2014; 119():169-89. PubMed ID: 25175966
[TBL] [Abstract][Full Text] [Related]
15. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A
Naser AFA; Aziz WM; Ahmed YR; Khalil WKB; Hamed MAA
Curr Aging Sci; 2022 Feb; 15(1):65-76. PubMed ID: 34042043
[TBL] [Abstract][Full Text] [Related]
17. A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.
Varani K; Vincenzi F; Tosi A; Gessi S; Casetta I; Granieri G; Fazio P; Leung E; MacLennan S; Granieri E; Borea PA
FASEB J; 2010 Feb; 24(2):587-98. PubMed ID: 19776336
[TBL] [Abstract][Full Text] [Related]
18. Rotenone induced olfactory deficit in Parkinson's disease rat model: The protective role of adenosine A
Babatunde BR; Adeyeye TA; Johnson VF; Shallie PD
J Chem Neuroanat; 2023 Jan; 127():102188. PubMed ID: 36375741
[TBL] [Abstract][Full Text] [Related]
19. The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats.
Cabeza de Vaca S; Kannan P; Pan Y; Jiang N; Sun Y; Carr KD
Brain Res; 2007 Apr; 1142():100-9. PubMed ID: 17292868
[TBL] [Abstract][Full Text] [Related]
20. Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson's disease model.
Sayed AS; El Sayed NS; Budzyńska B; Skalicka-Woźniak K; Ahmed MK; Kandil EA
Life Sci; 2022 Dec; 310():121129. PubMed ID: 36306871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
